PMID- 28025466 OWN - NLM STAT- MEDLINE DCOM- 20170815 LR - 20181113 IS - 1884-8796 (Electronic) IS - 0916-8737 (Print) IS - 0916-8737 (Linking) VI - 52 IP - 0 DP - 2016 TI - Deterioration of epithelium mediated mechanisms in diabetic-antigen sensitized airways of guinea pigs. PG - 93-104 LID - 10.1540/jsmr.52.93 [doi] AB - BACKGROUND: The onset of diabetes causes disruption of respiratory epithelial mediators. The present study investigates whether diabetes modifies the epithelium mediated bronchial responses in hyper-reactive airway smooth muscle (ASM) primarily through nitric oxide (NO), cyclooxygenase (COX), and epithelium derived hyperpolarizing factor (EpDHF) pathways. METHODS: Experimental model of guinea pigs having hyper-reactive airways with or without diabetes were developed. The responses of tracheal rings to cumulative concentrations of acetylcholine (ACh) and isoproterenol (IP) in the presence and absence of epithelium and before and after incubation with NO, K(+)(ATP) and COX inhibitors, N-(omega)-Nitro-L-arginine methyl ester (L-NAME; 100 muM), glybenclamide (10 muM) and indomethacin (100 muM) were assessed. RESULTS: In diabetic guinea pigs with hyper-reactive airways, a decrease in ACh induced bronchoconstriction was observed after epithelium removal and after incubation with L-NAME/indomethacin, suggesting damage to NO/COX pathways. Hyper-reactivity did not alter the response of trachea to ACh but affected the response to IP which was further reduced in hyper-reactive animals with diabetes. The ASM response to IP after glybenclamide treatment did not alter in hyper-reactive guinea pigs and diabetic guinea pigs with hyper-reactive airways, suggesting damage to the EpDHF pathway. Treatment with indomethacin reduced IP response in the hyper-reactive model, and did not produce any change in diabetic model with hyper-reactive airways, indicating further disruption of the COX pathway. CONCLUSION: EpDHF pathway is damaged in hyper-reactive guinea pigs and in diabetic guinea pigs with hyper-reactive airways. Diabetes further aggravates the NO and COX mediated pathways in diabetic guinea pigs with hyper-reactive airways. FAU - Bano, Saidullah AU - Bano S AD - Department of Physiology, VP Chest Institute, University of Delhi, Delhi, India. FAU - Swati, Omanwar AU - Swati O FAU - Kambadur, Muralidhar AU - Kambadur M FAU - Mohammad, Fahim AU - Mohammad F LA - eng PT - Journal Article PL - Japan TA - J Smooth Muscle Res JT - Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi JID - 9211664 RN - 0 (Antigens, Bacterial) RN - 0 (Bacterial Proteins) RN - 0 (invJ protein, Salmonella typhimurium) RN - 31C4KY9ESH (Nitric Oxide) RN - 5W494URQ81 (Streptozocin) RN - EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthases) RN - L628TT009W (Isoproterenol) RN - N9YNS0M02X (Acetylcholine) RN - SX6K58TVWC (Glyburide) RN - XXE1CET956 (Indomethacin) SB - IM MH - Acetylcholine/immunology MH - Animals MH - Antigens, Bacterial MH - Bacterial Proteins MH - Bronchial Hyperreactivity/*immunology/*pathology MH - Bronchoconstriction/immunology MH - Diabetes Complications/*immunology/*pathology MH - Diabetes Mellitus, Experimental/*immunology/*pathology MH - Female MH - Glyburide/pharmacology MH - Guinea Pigs MH - Humans MH - Indomethacin/pharmacology MH - Isoproterenol/immunology MH - Male MH - Muscle, Smooth/immunology/pathology MH - Nitric Oxide MH - Prostaglandin-Endoperoxide Synthases MH - Respiratory Mucosa/*immunology/*pathology MH - Streptozocin MH - Trachea/*immunology/*pathology PMC - PMC5321855 EDAT- 2016/12/28 06:00 MHDA- 2017/08/16 06:00 PMCR- 2016/01/01 CRDT- 2016/12/28 06:00 PHST- 2016/12/28 06:00 [entrez] PHST- 2016/12/28 06:00 [pubmed] PHST- 2017/08/16 06:00 [medline] PHST- 2016/01/01 00:00 [pmc-release] AID - 0467 [pii] AID - 10.1540/jsmr.52.93 [doi] PST - ppublish SO - J Smooth Muscle Res. 2016;52(0):93-104. doi: 10.1540/jsmr.52.93.